Oral Radiology

, 24:55 | Cite as

99mTc-MDP bone uptake in secondary hyperparathyroidism: comparison of the mandible, cranium, radius, and femur

  • Edson Boasquevisque
  • Jorge Wagner Esteves da Silva
  • Vanessa V. de Albuquerque Bernardo
  • Sara Mello Santana de Macedo
  • Camila S. Boasquevisque
  • André Ribeiro Nogueira de Oliveira
  • Erika Tami Pires Kasai
  • Carlos A. Mandarim-de-Lacerda
Original Article

Abstract

Objectives

To evaluate the bone involvement of the mandible, cranium, radius, and femur in secondary hyperparathyroidism (SHPT) using 99mTc-MDP uptake correlated with the serum intact parathyroid hormone (PTHi).

Methods

In a prospective study of 54 patients with SHPT due to chronic renal disease and 15 normal individuals (control group), all patients had elevated serum PTHi and positive 99mTc-MDP bone scintigraphy. Bone uptake was measured in regions of interest (ROIs) in the mandible, posterior cranium, distal radius, and proximal femur. In addition, soft tissue uptake was measured in one ROI in the soft tissues of the medial thigh (BG). The ROI-BG ratio was used as an index of the normalized bone uptake.

Results

The uptake differences in the SHPT and control groups were statistically significant for the mandible (P = 0.001) and cranium (P = 0.002). When the SHPT group was subclassified according to serum PTHi levels, the bone uptake increased with the serum PTHi level. All mandibles of the patients with SHPT were abnormal, and 33% had focal lesions.

Conclusions

The bone uptake in the SHPT group was abnormal in all areas evaluated, and a high uptake of 99mTc-MDP was correlated with an increased serum PTHi.

Key words

Secondary hyperparathyroidism Scintigraphy 99mTc-MDP Mandible 

References

  1. 1.
    Duarte ME, Peixoto AL, Pacheco AS, Peixoto AV, Rodriguez RD, Lugon JR, et al. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings. Sao Paulo Med J 1998;116:1790–1797.PubMedCrossRefGoogle Scholar
  2. 2.
    Ritz E, Krempien B, Mehls O, Malluche H. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int 1973;4:116–127.PubMedCrossRefGoogle Scholar
  3. 3.
    Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995;333:166–174.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferreira A, Drueke TB. Biological markers in the diagnosis of the different forms of renal osteodystrophy. Am J Med Sci 2000;320:85–89.PubMedCrossRefGoogle Scholar
  5. 5.
    Roe S, Cassidy MJ. Diagnosis and monitoring of renal osteodystrophy. Curr Opin Nephrol Hypertens 2000;9:675–681.PubMedCrossRefGoogle Scholar
  6. 6.
    Fogelman I, Bessent R. Age-related alterations in skeletal metabolism — 24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication. J Nucl Med 1982;23:296–300.PubMedGoogle Scholar
  7. 7.
    Sy WM, Mittal AK. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol 1975;48:878–884.PubMedGoogle Scholar
  8. 8.
    Brecht-Krauss D, Kusmierek J, Hellwig D, Adam WE. Quantitative bone scintigraphy in patients with hyperparathyroidism. J Nucl Med 1987;28:458–461.PubMedGoogle Scholar
  9. 9.
    Fogelman I, Collier BD, Brown ML. Bone scintigraphy: part 3. Bone scanning in metabolic bone disease. J Nucl Med 1993;34:2247–2252.PubMedGoogle Scholar
  10. 10.
    Fogelman I, Citrin DL, Turner JG, Hay ID, Bessent RG, Boyle IT. Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index. Eur J Nucl Med 1979;4:287–289.PubMedCrossRefGoogle Scholar
  11. 11.
    Pitt WR, Sharp PF. Comparison of quantitative and visual detection of new focal bone lesions. J Nucl Med 1985;26:230–236.PubMedGoogle Scholar
  12. 12.
    Fletcher JW, Solaric-George E, Henry RE, Donati RM. Radioisotopic detection of osseous metastases. Evaluation of 99mTc polyphosphate and 99mTc pyrophosphate. Arch Intern Med 1975;135:553–557.PubMedCrossRefGoogle Scholar
  13. 13.
    Alvarez L, Peris P, Pons F, Guanabens N, Herranz R, Monegal A, et al. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget’s disease activity. Arthritis Rheum 1997;40:461–468.PubMedCrossRefGoogle Scholar
  14. 14.
    Nishida H, Kaida H, Ishibashi M, Hiromatsu Y, Baba K, Iida S, et al. Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients. Ann Nucl Med 2005;19:91–94.PubMedGoogle Scholar
  15. 15.
    Nishida H, Ishibashi M, Hiromatsu Y, Kaida H, Baba K, Miyake I, et al. Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyper-parathyroid glands. Endocr J 2005;52:223–228.PubMedCrossRefGoogle Scholar
  16. 16.
    Kaida H, Ishibashi M, Nishida H, Baba K, Hiromatsu Y, Okuda S, et al. Assessment of therapeutic effect in patients with secondary hyperparathyroidism using bone scintigraphy. Ann Nucl Med 2005;19:367–372.PubMedCrossRefGoogle Scholar
  17. 17.
    Kurata S, Ishibashi M, Nishida H, Hiromatsu Y, Hayabuchi N. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients. Ann Nucl Med 2004;18:513–518.PubMedCrossRefGoogle Scholar
  18. 18.
    Frost HM. Bone dynamics in metabolic bone disease. J Bone Joint Surg Am 1966;48:1192–1203.PubMedGoogle Scholar
  19. 19.
    Adami S, Braga V, Squaranti R, Rossini M, Gatti D, Zamberlan N. Bone measurements in asymptomatic primary hyperparathyroidism. Bone 1998;22:565–570.PubMedCrossRefGoogle Scholar
  20. 20.
    Fogelman I, Bessent RG, Cohen HN, Hart DM, Lindsay R. Skeletal uptake of diphosphonate. Method for prediction of postmenopausal osteoporosis. Lancet 1980;2:667–670.PubMedCrossRefGoogle Scholar
  21. 21.
    Kerr AR. Update on renal disease for the dental practitioner. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:9–16.PubMedCrossRefGoogle Scholar
  22. 22.
    Charhon SA, Berland YF, Olmer MJ, Delawari E, Traeger J, Meunier PJ. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 1985;27:426–435.PubMedCrossRefGoogle Scholar
  23. 23.
    Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. J Nucl Med 1981;22:880–883.PubMedGoogle Scholar
  24. 24.
    Francis MD, Ferguson DL, Tofe AJ, Bevan JA, Michaels SE. Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). J Nucl Med 1980;21:1185–1189.PubMedGoogle Scholar
  25. 25.
    Kalyvas D, Tosios KI, Leventis MD, Tsiklakis K, Angelopoulos AP. Localized jaw enlargement in renal osteodystrophy: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:68–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Kasai ETP, Silva JWE, Mandarim-de-Lacerda CA, Boasquevisque E. Parathyroid glands: combination of sestamibi-99mTc and ultrasonography for demonstration of hyperplasic parathyroid glands. Rev Esp Med Nucl 2008;27:8–12.PubMedCrossRefGoogle Scholar
  27. 27.
    McKillop JH, Fogelman I. Bone scintigraphy in benign bone disease. Br Med J (Clin Res Ed) 1984;288:264–266.Google Scholar
  28. 28.
    Brown ML. Bone scintigraphy in benign and malignant tumors. Radiol Clin North Am 1993;31:731–738.PubMedGoogle Scholar
  29. 29.
    Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967;18:158–162.PubMedCrossRefGoogle Scholar
  30. 30.
    Thrall JH, Ellis BI. Skeletal metastases. Radiol Clin North Am 1987;25:1155–1170.PubMedGoogle Scholar
  31. 31.
    Collier BD Jr, Fogelman I, Brown ML. Bone scintigraphy: part 2. Orthopedic bone scanning. J Nucl Med 1993;34:2241–2246.PubMedGoogle Scholar
  32. 32.
    Wiegmann T, Rosenthall L, Kaye M. Technetium-99m-pyrophosphate bone scans in hyperparathyroidism. J Nucl Med 1977;18:231–235.PubMedGoogle Scholar
  33. 33.
    Ritz E, Prager P, Krempien B, Bommer J, Malluche HH, Schmidt-Gayk H. Skeletal X-ray findings and bone histology in patients on hemodialysis. Kidney Int 1978;13:316–323.PubMedCrossRefGoogle Scholar
  34. 34.
    Galasko CS. Proceedings: the pathological basis for skeletal scintigraphy. Br J Radiol 1975;48:72–73.PubMedGoogle Scholar
  35. 35.
    Galasko CS. The pathological basis for skeletal scintigraphy. J Bone Joint Surg Br 1975;57:353–359.PubMedGoogle Scholar
  36. 36.
    Khan O, Archibald A, Thomson E, Maharaj P. The role of quantitative single photon emission computerized tomography (SPECT) in the osseous integration process of dental implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:228–232.PubMedCrossRefGoogle Scholar
  37. 37.
    Oktar FN, Kesenci K, Piskin E. Characterization of processed tooth hydroxyapatite for potential biomedical implant applications. Artif Cells Blood Substit Immobil Biotechnol 1999;27:367–379.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society for Oral and Maxillofacial Radiology and Springer Japan 2008

Authors and Affiliations

  • Edson Boasquevisque
    • 1
  • Jorge Wagner Esteves da Silva
    • 2
  • Vanessa V. de Albuquerque Bernardo
    • 3
  • Sara Mello Santana de Macedo
    • 3
  • Camila S. Boasquevisque
    • 4
  • André Ribeiro Nogueira de Oliveira
    • 3
  • Erika Tami Pires Kasai
    • 3
  • Carlos A. Mandarim-de-Lacerda
    • 1
  1. 1.Laboratório de Medicina Nuclear Experimental, Departamento de AnatomiaInstituto de Biologia Roberto Alcântara GomesRio de JaneiroBrasil
  2. 2.Departamento de Patologia e Laboratórios, Faculdade de Ciências MédicasUniversidade do Estado do Rio de JaneiroJaneiroBrasil
  3. 3.Serviço de Medicina Nuclear, Hospital Universitário Pedro ErnestoUniversidade do Estado do Rio de JaneiroJaneiroBrasil
  4. 4.Faculdade de OdontologiaUniversidade do Estado do Rio de JaneiroJaneiroBrasil

Personalised recommendations